Mexico will receive the World Scientific Conference on HIV
MEXICAN CITY COUNCIL
Mexico will make its second World Scientific Conference on HIV / AIDS in 2019. In it, more than 6,000 participants will gather to analyze the latest scientific advances, treatments and needs of patients with this condition.
At the press conference, Dr. Brenda Crabtree, according to the President of the International AIDS Association (IAS), will take place from 24 to 24 July 2019 and will include a possible outlook on this illness.
"There has been a lot of progress, a lot of research has been done, but there is still a lot going on about this disease, and we will discuss this incident," said the specialist.
In the event that will take place in Mexico City, experts from more than 120 countries will participate in the study of HIV and public health response.
It will be the tenth edition of the conference, and the important advances made by Crabtre in Latin America since 2008 were held in Mexico, for the first time.
"The number of people who know about diagnosis and treatment has increased, however, they continue to face violence and stigma against vulnerable populations to advance in this disease."
Likewise, Latin America and the Caribbean are commonly seen as a small region that causes this virus, with 2.1 million people living in HIV in the region, and the Caribbean has the second highest prevalence rate. After HIV, after sub-Saharan Africa.
In Mexico, until 2017, coverage was 65% diagnosis, 61% in treatment and 51% in antivirus treatment, and 80% of the people diagnosed in the coming years are expected to arrive. -90-90 World Health Organization (WHO).
Crabtree's highest prevalence conditions are transsexual women (20%), men with men, 10 to 15 years of age, and 5% of consumers injecting drugs.
At the congress, new research on illness will be presented, specialists say that Mexico has made significant progress.
"We have achieved a great deal of research, but we continue to be a limited budget and the government must also move on in this direction," said Dr. Salvador Zubirán, researcher at the GIB National Institute of Medicine and Food Science (INCMNSZ).
During the event, practice classes and strategies will be effective in stigmatization and discrimination to reduce the gap between the weakest populations of health services and communities.
Censida is required to strengthen HIV / AIDS actions